DSE/AMBEEPHA (DSE/AMBEEPHA)

Dhaka Stock Exchange: DSE/AMBEEPHA · BDT

BDT 737

-4.20 (-0.6%)· Recorded snapshot

Market cap	1.8B
Revenue (ttm)	157.6M
Net income (ttm)	5.5M
EPS (ttm)	BDT 2.30
Shares out	2.4M
P/E (trailing)	319.8x
Dividend	BDT 1.00 (0.14%)
Volume	399
Beta	-0.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 157.6M
Net income (ttm): 5.5M
EPS (ttm): BDT 2.30
P/E (trailing): 319.8x
Market cap: 1.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E319.8

P25 n/aP50 n/aP75 n/a

ROE16.4

P25 n/aP50 n/aP75 n/a

ROIC0.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DSE/AMBEEPHA indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

BDT

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-10-29
Employees	474
Employees change	-55
Employees growth	-10.4%
Enterprise value	BDT 2.3B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	1976
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BD0451AMBPH6
Last earnings date	2026-04-29
Last refreshed	2026-10-29
Last stock split date	2014-05-29
Last stock split type	Forward
Market cap	BDT 1.8B
Price	BDT 736.50
Price currency	BDT
SIC code	2834
Stock price date	2026-10-28
Symbol	dse/AMBEEPHA
Website	https://www.ambeepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	279.81x
Average P/E ratio (3Y)	233.31x
Average P/E ratio (5Y)	210.64x
Earnings yield	0.31%
EV/Earnings	421.56x
EV/EBITDA	263.14x
EV/Sales	14.78x
FCF / EV yield	-0.79%
FCF yield	-1.04%
Graham number	27.63059
Graham upside	-96.25%
Industry P/E	9.79x
Lynch fair value	BDT 11.52
Lynch upside	-98.44%
P/B ratio	49.99x
P/E ratio	319.79x
P/S ratio	11.21x
Price / tangible book value	49.99x
Price/EBITDA ratio	208x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.57%
EBITDA margin	5.39%
Effective tax rate	27.49%
Gross margin	46.28%
Operating margin	2.57%
Pretax margin	4.84%
Profit margin	3.51%
Profit per employee	BDT 11,661
Revenue per employee	BDT 332,515
ROA	0.34%
ROA (5Y)	0.93%
ROCE	10.41%
ROE	16.36%
ROE (5Y)	13.8%
ROIC	0.5%
Tax / revenue	1.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-45.16%
EPS growth (Q)	-52.82%
EPS growth (QoQ)	-70.44%
EPS growth 10Y	-1.67%
EPS growth 3Y	-16.54%
Gross profit growth	-41.5%
Gross profit growth (Q)	-47.84%
Gross profit growth 3Y	-10.87%
Gross profit growth 5Y	-1.99%
Net income growth	-45.16%
Net income growth (Q)	-52.81%
Net income growth (QoQ)	-70.44%
Net income growth 3Y	-16.54%
Operating income growth	-69.03%
Operating income growth (Q)	-29.94%
Operating income growth 3Y	-36.51%
Operating income growth 5Y	-8.06%
Revenue growth	-32.99%
Revenue growth (Q)	-47.84%
Revenue growth (QoQ)	-32.98%
Revenue growth 10Y	-7.61%
Revenue growth 3Y	-6.22%
Revenue growth 5Y	1.45%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BDT 254
Depreciation and amortization	BDT 4.4M
EBIT	BDT 4.1M
EBITDA	BDT 8.5M
EPS	BDT 2.30
FCF per share	BDT -7.67
Financing cash flow	BDT 30M
Free cash flow	BDT -18.4M
Gross profit	BDT 72.9M
Income taxes	BDT 2.1M
Investing cash flow	BDT -15.6M
Net borrowing	BDT 36.3M
Net cash flow	BDT -4.1M
Net income	BDT 5.5M
Operating income	BDT 4.1M
Revenue	BDT 157.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.63
Book value per share	BDT 14.73
Debt / EBITDA	74.58
Debt / equity	18.68
Interest coverage	119.99
Long-term assets	BDT 149.1M
Long-term liabilities	BDT 3.6M
Net cash (debt)	BDT -562.5M
Net cash / market cap	-31.83%
Net debt / EBITDA	66.2
Net debt / equity	15.91
Piotroski F-Score	2
Property, plant and equipment	BDT 96.5M
Shareholders' equity	BDT 35.4M
Tangible book value	BDT 35.4M
Tangible book value per share	BDT 14.73
Total assets	BDT 758.5M
Total cash	BDT 97.9M
Total debt	BDT 660.4M
Total liabilities	BDT 723.1M
WACC	2.21%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.21
Current assets	BDT 609.3M
Current liabilities	BDT 719.5M
Current ratio	0.85
Inventory turnover	0.36
Net working capital	BDT 452.1M
Quick ratio	0.44
Working capital	BDT -110.2M
Working capital turnover	-1.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	0%
Dividend growth (10Y)	-9.78%
Dividend growth (3Y)	0%
Dividend growth (5Y)	-7.79%
Dividend growth years	0
Dividend payment date	2026-01-18
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	BDT 1.00
Dividend yield	0.14%
Ex-dividend date	2025-11-23
Last dividend	BDT 1.00
Payout ratio	39.37%
Shareholder yield	0.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	76.83%
10Y return CAGR	6.25%
10Y total return	83.32%
150-day SMA	BDT 766.46
15Y price change	113.69%
15Y return CAGR	5.74%
15Y total return	130.82%
1D price change	-0.57%
1M price change	-1.68%
1M total return	-1.68%
1Y price change	-8.03%
1Y return CAGR	-7.91%
1Y total return	-7.91%
20-day SMA	BDT 740.15
200-day SMA	BDT 759.17
20Y price change	1,908.62%
20Y return CAGR	17.21%
20Y total return	2,294.27%
3M price change	-10.87%
3M total return	-10.87%
3Y price change	-36.16%
3Y return CAGR	-13.76%
3Y total return	-35.86%
50-day SMA	BDT 750.48
50-day SMA vs 200-day SMA	50under200
52-week high	BDT 847.00
52-week high date	2026-07-21
52-week low	BDT 681.00
52-week low date	2025-12-18
5Y price change	54.79%
5Y return CAGR	9.27%
5Y total return	55.8%
6M price change	-2.15%
6M total return	-2.15%
All-time high	BDT 1,302.30
All-time high date	2023-10-30
All-time low	BDT 6.91
All-time low date	1996-05-06
Average true range (ATR)	BDT 16.70
Average volume	449.3
Beta (1Y)	-0.07
Beta (2Y)	-0.04
Beta (5Y)	-0.22
Change from 52-week high	-13.05%
Change from 52-week low	8.15%
Change from all-time high	-43.45%
Change from all-time low	10,560.01%
Change from open	-0.57%
Day's gap	0%
Dollar volume	BDT 293,864
High price	BDT 748.00
Low price	BDT 735.10
Monthly RSI	47.44
Open price	BDT 740.70
Position in 52-week range	10.85%
Previous close	BDT 740.70
Price vs 150-day SMA	-3.91%
Price vs 20-day SMA	-0.49%
Price vs 200-day SMA	-2.99%
Price vs 50-day SMA	-1.86%
Relative volume	0.85
RSI	39.27
Sharpe ratio	-0.61
Sharpe ratio (3Y)	0.2
Sharpe ratio (5Y)	0.37
Sortino ratio	-0.61
Sortino ratio (3Y)	0.49
Sortino ratio (5Y)	0.76
Volume	399
Weekly RSI	98.71
YTD price change	4.03%
YTD total return	4.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	545.9K
Shares change (QoQ)	0%
Shares held by insiders	77.25%
Shares outstanding	2.4M

Deeper analysis on DSE/AMBEEPHA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DSE/AMBEEPHA report

Is a complete DSE/AMBEEPHA research report available?

No complete published report is available for dse/AMBEEPHA (DSE/AMBEEPHA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/AMBEEPHA (DSE/AMBEEPHA)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/AMBEEPHA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/AMBEEPHA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/AMBEEPHA

Frequently asked questions